Wearable Devices CSO reports initial holdings
Wearable Devices Ltd. director and executive officer Wagner Guy filed an initial ownership report showing his equity position in the company.
Rhea-AI Filing Summary
Wearable Devices Ltd. director and executive officer Wagner Guy filed an initial ownership report showing his equity position in the company. He directly holds 74,583 Ordinary Shares, along with restricted share units that can convert into additional shares over time as they vest.
The filing also lists two stock option awards. One option covers 125 Ordinary Shares at an exercise price of 316.8000, vesting partly on August 23, 2024 and then in monthly installments. A second option covers 208 Ordinary Shares at an exercise price of 104.1600, vesting from August 15, 2025 in monthly installments. The document records these as holdings, not new market purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Wagner Guy
Role
CSO and President
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock option (right to buy) | -- | -- | -- |
| holding | Stock option (right to buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Stock option (right to buy) — 333 contracts (Direct);
Ordinary Shares — 74,583 shares (Direct)
Footnotes (3)
- F1. Includes (i) 6,250 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") in equal monthly installments of 1,042 Ordinary Shares through September 10, 2026; and (ii) 47,222 Ordinary Shares issuable upon the vesting of RSUs in equal monthly installments of 1,389 Ordinary Shares through January 1, 2029. Each RSU represents the right to receive one Ordinary Share.
- F2. The options were granted on November 30, 2023 and vest as follows: 42 options vest on August 23, 2024 and the remaining 83 options vest in equal monthly installments of 3 Ordinary Shares thereafter.
- F3. The options were granted on September 26, 2024 and vest as follow: 69 options vest August 15, 2025 and the remaining 139 options vest in equal monthly installments of 6 Ordinary Shares thereafter.
Key Figures
Ordinary Shares held: 74,583 shares
RSUs tranche 1: 6,250 shares
RSUs tranche 2: 47,222 shares
+4 more
7 metrics
Ordinary Shares held
74,583 shares
Direct holdings reported on Form 3
RSUs tranche 1
6,250 shares
RSUs vesting 1,042 shares monthly through September 10, 2026
RSUs tranche 2
47,222 shares
RSUs vesting 1,389 shares monthly through January 1, 2029
Option 1 exercise price
316.8000 per share
Stock option on 125 Ordinary Shares, expires November 30, 2033
Option 1 underlying shares
125 shares
First stock option grant vesting from August 23, 2024
Option 2 exercise price
104.1600 per share
Stock option on 208 Ordinary Shares, expires September 26, 2034
Option 2 underlying shares
208 shares
Second stock option grant vesting from August 15, 2025
Key Terms
restricted share units ("RSUs"), Stock option (right to buy), Ordinary Shares, exercise price, +1 more
5 terms
Stock option (right to buy) financial
"security_title: "Stock option (right to buy)""
exercise price financial
"exercisePrice: "316.8000" and "104.1600" for stock options on Ordinary Shares"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"RSUs vest in equal monthly installments and options vest in specified tranches after initial dates"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Wearable Devices (WLDS) Form 3 filing show for Wagner Guy?
The Form 3 shows that Wagner Guy, a director and CSO/President, reports ownership of 74,583 Ordinary Shares plus equity awards, including restricted share units and stock options with defined vesting schedules and exercise prices, all recorded as existing holdings rather than new market trades.
What stock options does Wagner Guy hold in Wearable Devices (WLDS)?
He holds a stock option for 125 Ordinary Shares with a 316.8000 exercise price, expiring November 30, 2033, and another for 208 Ordinary Shares with a 104.1600 exercise price, expiring September 26, 2034. Both options vest in tranches beginning in 2024 and 2025, respectively.
Does the Wearable Devices (WLDS) Form 3 indicate insider buying or selling by Wagner Guy?
The Form 3 lists Wagner Guy’s existing holdings and equity awards, classifying entries as holdings with unknown transaction codes. The transaction summary shows no buy or sell counts, indicating this filing is an initial ownership report rather than a record of new market purchases or sales.
AI-generated analysis. How Rhea-AI works. Not financial advice.
